Efficacy of intravenous immunoglobulin in shrinking lung syndrome associated with mixed connective tissue disease: a case report.
Abstract
Shrinking lung syndrome is a rare manifestation of connective tissue diseases, namely systemic lupus erythematosus. It is characterised by reduced lung volumes and extra-pulmonary restrictive ventilatory pattern with good response to high-dose glucocorticoids alone or in combination with a second immunosuppressive agent. Here, we describe a case associated with mixed connective tissue disease and effectively treated with intravenous immunoglobulin.
Overview publication
Title | Efficacy of intravenous immunoglobulin in shrinking lung syndrome associated with mixed connective tissue disease: a case report. |
Date | 2022-05-01 |
Issue name | Clinical and experimental rheumatology |
Issue number | v40 Suppl 134.5:116-117 |
DOI | 10.55563/clinexprheumatol/aotrf1 |
PubMed | 35084319 |
Authors | |
Read | Read publication |